HCPCS Level IIdrugActive
J3379
Inj, valproate sod, 5 mg
BETOS: O1E
Effective: 2026-01-01
Description
Injection, valproate sodium, 5 mg
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Valproate Sodium
Manufacturer
Hikma Pharmaceuticals USA Inc.
HCPCS Dosage
5 MG
Billing Units
100.0000
6
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.